Current Generation Integrated Instrumentation for H-D Exchange LC-MS

适用于 HD Exchange LC-MS 的最新一代集成仪器

基本信息

  • 批准号:
    7839879
  • 负责人:
  • 金额:
    $ 101.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-15 至 2012-04-14
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application requests funds to purchase current-generation instrumentation for the performance of state-of- the-art peptide amide hydrogen-deuterium exchange mass spectrometry (DXMS), to replace the obsolete instrumentation presently used in the UCSD DXMS Resource. Integrated sample preparation, liquid chromatography, and mass spectroscopic instrumentation is requested: 1. A Thermo Fisher LTQ Orbitrap Velos mass spectrometer with electron transfer dissociation (ETD) (ORBXL-0723870) for dedicated DXMS use in the Resource; 2. A LEAP Technology H/D-X PAL Hydrogen-Deuterium Exchange sample preparation and injection platform; 3. A Waters nanoACQUITY UPLC System for the performance of rapid, high resolution, and high-sensitivity chromatographic separation of proteolytic digests of deuterated protein samples prepared on the LEAP H/D-X PAL. The UCSD DXMS Resource provides facile access to state-of-the-art DXMS technology to NIH-funded investigators. Its twenty-one Major Users have a remarkable record of more than thirty top-tier DXMS-focused publications resulting from work performed in the Resource, and their combined total S10-eligible NIH funding for research that relies on studies performed in the Resource exceeds $9 M in direct costs per year. While the Resource has been highly productive, the sample preparation, chromatographic, and mass spectroscopic instrumentation (a Thermo LCQ Classic and Micromass Q-TOF I), in continuous DXMS use for more than 12 years, are now obsolete, and must be replaced with current generation DXMS-enabling equipment. Because of our capabilities and scientific productivity, requests to the Resource for DXMS study are accelerating. Advances made in the DXMS technology we employ in front of (sample processing chemistries) and after (data processing software), the mass spectrometers have made our old machines the rate-limiting step in both throughput, and quality of DXMS analysis. While any of a number of current-generation mass spectrometers would provide substantial improved throughput and quality of DXMS study, our analysis, and the experience of our consultants indicates that the Thermo LTQ Orbitrap Velos-ETD is a superior and cost-effective instrument for dedicated DXMS use. Together with the requested synergistic sample preparation and LC components, it will allow us to best provide for our current DXMS users, and position us to exploit further advances in DXMS technology, such as ETD-mediated deuteron sublocalization. PUBLIC HEALTH RELEVANCE: At the UCSD DXMS Resource, we provide many protein scientists with the ability to use a technically demanding, but most powerful mass spectrometry-based technology ("DXMS") to study precisely how the proteins they are interested in change shape as they perform their biologic functions. The growing demand for DXMS use requires that the Resource replace the now obsolete equipment that has been used for more than a decade, with the current generation DXMS instrumentation requested in this application.
描述(由申请人提供):本申请申请资金用于购买最先进的多肽酰胺氢-氚交换质谱仪(DXMS)的最新一代仪器,以取代UCSD DXMS资源中目前使用的过时仪器。1.带电子转移解离的Thermo Fisher LTQ Orbitrap Velos质谱仪(ORBXL-0723870),用于资源中专用的DXMS;2.LEAP技术H/D-X PAL氢-氘交换样品制备和进样平台;3.Waters纳米ACQUITY UPLC系统,用于快速、高分辨率、高灵敏度地分离在LEAP H/D-X PAL上制备的蛋白质水解性消化产物。加州大学圣迭戈分校的DXMS资源为NIH资助的研究人员提供了对最先进的DXMS技术的便捷访问。它的21个主要用户拥有超过30种顶级DXMS重点出版物的显著记录,这些出版物是由资源中所做的工作产生的,他们为依赖资源中所做研究的研究提供的符合S10标准的NIH资金加起来每年的直接成本超过900万美元。虽然该资源一直具有很高的生产力,但连续使用DXMS超过12年的样品制备、色谱和质谱仪(Thermo LCQ Classic和MicroMassQ-TOF I)现在已经过时,必须由支持DXMS的最新一代设备取代。由于我们的能力和科学生产力,对DXMS研究资源的要求正在加速。我们在(样品处理化学)和(数据处理软件)之前和之后采用的DXMS技术的进步,使我们的旧机器在吞吐量和DXMS分析质量方面都成为了限速步骤。虽然任何一种当前一代的质谱计都可以显著提高DXMS研究的吞吐量和质量,但我们的分析和我们顾问的经验表明,Thermo LTQ Orbitrap Velos-ETD是专门用于DXMS的一种卓越且经济高效的仪器。与所需的协同样品制备和LC组件一起,它将使我们能够最好地为我们当前的DXMS用户提供服务,并使我们能够利用DXMS技术的进一步进步,例如ETD介导的氘核子区块化。 公共卫生相关性:在加州大学圣迭戈分校的DXMS资源,我们为许多蛋白质科学家提供了使用技术要求高但功能最强大的基于质谱学的技术(“DXMS”)来精确研究他们感兴趣的蛋白质在执行其生物功能时如何改变形状的能力。不断增长的DXMS使用需求要求资源使用本申请中要求的新一代DXMS仪器更换已经使用了十多年的现已过时的设备。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fluoroketone inhibition of Ca(2+)-independent phospholipase A2 through binding pocket association defined by hydrogen/deuterium exchange and molecular dynamics.
  • DOI:
    10.1021/ja306490g
  • 发表时间:
    2013-01-30
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Hsu YH;Bucher D;Cao J;Li S;Yang SW;Kokotos G;Woods VL Jr;McCammon JA;Dennis EA
  • 通讯作者:
    Dennis EA
Lipoprotein-associated phospholipase A(2) interacts with phospholipid vesicles via a surface-disposed hydrophobic α-helix.
  • DOI:
    10.1021/bi101916w
  • 发表时间:
    2011-06-14
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Cao J;Hsu YH;Li S;Woods VL;Dennis EA
  • 通讯作者:
    Dennis EA
B-cell epitopes in GroEL of Francisella tularensis.
  • DOI:
    10.1371/journal.pone.0099847
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Lu Z;Rynkiewicz MJ;Madico G;Li S;Yang CY;Perkins HM;Sompuram SR;Kodela V;Liu T;Morris T;Wang D;Roche MI;Seaton BA;Sharon J
  • 通讯作者:
    Sharon J
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VIRGIL L WOODS其他文献

VIRGIL L WOODS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VIRGIL L WOODS', 18)}}的其他基金

DXMS-Facilitated Membrane Protein Construct Design/Cancer
DXMS 促进膜蛋白构建体设计/癌症
  • 批准号:
    7024358
  • 财政年份:
    2006
  • 资助金额:
    $ 101.11万
  • 项目类别:
DXMS-Facilitated Membrane Protein Construct Design/Cancer
DXMS 促进膜蛋白构建体设计/癌症
  • 批准号:
    7229903
  • 财政年份:
    2006
  • 资助金额:
    $ 101.11万
  • 项目类别:
Enhanced Crystallography of Cancer-Implicated Proteins
癌症相关蛋白质的增强晶体学
  • 批准号:
    6695771
  • 财政年份:
    2003
  • 资助金额:
    $ 101.11万
  • 项目类别:
Enhanced Crystallography of Cancer-Implicated Proteins
癌症相关蛋白质的增强晶体学
  • 批准号:
    6891547
  • 财政年份:
    2003
  • 资助金额:
    $ 101.11万
  • 项目类别:
Enhanced Crystallography of Cancer-Implicated Proteins
癌症相关蛋白质的增强晶体学
  • 批准号:
    6896111
  • 财政年份:
    2003
  • 资助金额:
    $ 101.11万
  • 项目类别:
Enhanced Crystallography of Cancer-Implicated Proteins
癌症相关蛋白质的增强晶体学
  • 批准号:
    7067585
  • 财政年份:
    2003
  • 资助金额:
    $ 101.11万
  • 项目类别:
TREATMENT OF OSTEOSARCOMA WITH INTEGRIN-PERTURBING DRUGS
用干扰整合素的药物治疗骨肉瘤
  • 批准号:
    2099212
  • 财政年份:
    1993
  • 资助金额:
    $ 101.11万
  • 项目类别:
TREATMENT OF OSTEOSARCOMA WITH INTEGRIN-PERTURBING DRUGS
用干扰整合素的药物治疗骨肉瘤
  • 批准号:
    2099211
  • 财政年份:
    1993
  • 资助金额:
    $ 101.11万
  • 项目类别:
TREATMENT OF OSTEOSARCOMA WITH INTEGRIN-PERTURBING DRUGS
用干扰整合素的药物治疗骨肉瘤
  • 批准号:
    3202665
  • 财政年份:
    1993
  • 资助金额:
    $ 101.11万
  • 项目类别:
STRUCTURE AND FUNCTION OF PLATELET GPIIB/IIIA
血小板 GPIIB/IIIA 的结构和功能
  • 批准号:
    3341504
  • 财政年份:
    1983
  • 资助金额:
    $ 101.11万
  • 项目类别:

相似国自然基金

Handbook of the Mathematics of the Arts and Sciences的中文翻译
  • 批准号:
    12226504
  • 批准年份:
    2022
  • 资助金额:
    20.0 万元
  • 项目类别:
    数学天元基金项目
促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
  • 批准号:
    81372444
  • 批准年份:
    2013
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目
雄性锹甲的生殖对策抉择ARTs及其进化机制-基于行为与SSRs标记的整合研究
  • 批准号:
    31201745
  • 批准年份:
    2012
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Games, Heritage, Arts, & Sport: the economic, social, and cultural value of the European videogame ecosystem (GAMEHEARTS)
游戏、遗产、艺术、
  • 批准号:
    10104584
  • 财政年份:
    2024
  • 资助金额:
    $ 101.11万
  • 项目类别:
    EU-Funded
Open Access Block Award 2024 - University of the Arts London
2024 年开放获取区块奖 - 伦敦艺术大学
  • 批准号:
    EP/Z532216/1
  • 财政年份:
    2024
  • 资助金额:
    $ 101.11万
  • 项目类别:
    Research Grant
ARTS: Broadening capacity for research on gall wasps in North America
ARTS:扩大北美瘿蜂研究能力
  • 批准号:
    2338008
  • 财政年份:
    2024
  • 资助金额:
    $ 101.11万
  • 项目类别:
    Continuing Grant
REU Site: Summer Research Program for Community College and Liberal Arts College Students in Physics and Astronomy
REU 网站:社区学院和文理学院学生物理和天文学夏季研究计划
  • 批准号:
    2349111
  • 财政年份:
    2024
  • 资助金额:
    $ 101.11万
  • 项目类别:
    Continuing Grant
Building Partnerships to Recruit Recent STEM Graduates into a Masters of Arts in Teaching Program
建立合作伙伴关系,招募应届 STEM 毕业生加入教学硕士项目
  • 批准号:
    2345165
  • 财政年份:
    2024
  • 资助金额:
    $ 101.11万
  • 项目类别:
    Standard Grant
Enhancing Faculty Well-being at Liberal Arts Colleges: Individual, Contextual, Institutional, and Cultural Factors
提高文理学院教师的福祉:个人、背景、制度和文化因素
  • 批准号:
    24K06445
  • 财政年份:
    2024
  • 资助金额:
    $ 101.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Art and Policy in the Global Contemporary: Examining the Role of the Arts in the Production of Public Policy
全球当代的艺术与政策:审视艺术在公共政策制定中的作用
  • 批准号:
    EP/Y036972/1
  • 财政年份:
    2024
  • 资助金额:
    $ 101.11万
  • 项目类别:
    Research Grant
地理総合における対話型鑑賞法を援用したArts-STEM型教科融合授業モデルの開発
利用综合地理学中的互动欣赏方法开发艺术-STEM型学科融合课堂模型
  • 批准号:
    24H02463
  • 财政年份:
    2024
  • 资助金额:
    $ 101.11万
  • 项目类别:
    Grant-in-Aid for Encouragement of Scientists
Arts4Us - Working Together to Scale up Place-Based Arts Initiatives that Support the Mental Health of Children and Young People
Arts4Us - 共同努力扩大支持儿童和青少年心理健康的地方艺术举措
  • 批准号:
    AH/Z505493/1
  • 财政年份:
    2024
  • 资助金额:
    $ 101.11万
  • 项目类别:
    Research Grant
ARTS: A corevision of the pinhole borers (Coleoptera: Curculionidae: Platypodinae) and symbiotic fungi (Raffaelea spp.) via multi-generational systematics training
艺术:通过多代系统学训练对针孔蛀虫(鞘翅目:象甲科:扁豆亚科)和共生真菌(拉斐菌属)进行共同观察
  • 批准号:
    2342481
  • 财政年份:
    2024
  • 资助金额:
    $ 101.11万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了